Pluripotent stem cells are the starting cell type of choice for the development of many cell-based regenerative therapies due to their rapid and unlimited proliferation and broad differentiation potential. The unique pluripotent cell cycle underlies both these properties. Hyperpolarization-activated cyclic nucleotide-gated cation (HCN) family channels have previously been reported to modulate mouse embryonic stem cell (ESC) proliferation and here we characterize the effects of HCN inhibitor ZD7288 on ESC proliferation and stem cell identity. The doubling time of cells treated with the HCN blocker increased by ~30 % due to longer G1 and S phases, resulting in a nearly twofold reduction in ESC numbers after 4 day serum-free culture. Slower progression through S phase was not accompanied by H2AX phosphorylation or cell stalling at transition points, although EdU incorporation in treated cells was reduced. Despite the drastic cell cycle perturbations, the pluripotent status of the cells was not compromised by treatment. Cultures treated with the HCN blocker in maintenance conditions maintained pluripotency marker expression on both RNA and protein level, although we observed a reversible effect on morphology and colony formation frequency. Addition of ZD7288 in differentiating media improved FBS-driven differentiation, but not directed differentiation to neuroectoderm, further indicating that altered cell cycle structure does not necessarily compromise pluripotency and drive ESCs to differentiation. The categorically different outcomes of ZD7288 use during differentiation indicate that cell culture context can be determinative for effects of ion-modulatory molecules and underscores the need for exploring their action in serum-free conditions demanded by potential clinical use.

Department of Physiology and Pharmacology Karolinska Institutet 171 77 Stockholm Sweden

Department of Physiology and Pharmacology Karolinska Institutet 171 77 Stockholm Sweden ; Central European Institute of Technology Masaryk University Kamenice 735 5 625 00 Brno Czech Republic

See more in PubMed

Andang M, Hjerling-Leffler J, Moliner A, Lundgren TK, Castelo-Branco G, Nanou E, Pozas E, Bryja V, Halliez S, Nishimaru H, Wilbertz J, Arenas E, Koltzenburg M, Charnay P, El Manira A, Ibanez CF, Ernfors P. Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature. 2008;451(7177):U460–U464. doi: 10.1038/nature06488. PubMed DOI

Andang M, Moliner A, Doege CA, Ibanez CF, Ernfors P. Optimized mouse ES cell culture system by suspension growth in a fully defined medium. Nat Protoc. 2008;3(6):1013–1017. doi: 10.1038/nprot.2008.65. PubMed DOI

Ballabeni A, Park I-H, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. Cell cycle adaptations of embryonic stem cells. Proc Natl Acad Sci. 2011;108(48):19252–19257. doi: 10.1073/pnas.1116794108. PubMed DOI PMC

Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, van Wijnen AJ, Stein GS. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol. 2006;209(3):883–893. doi: 10.1002/jcp.20776. PubMed DOI

Biel M, Wahl-Schott C, Michalakis S, Zong XG. Hyperpolarization-activated cation channels: from genes to function. Physiol Rev. 2009;89(3):847–885. doi: 10.1152/physrev.00029.2008. PubMed DOI

Bror S. The SLC38 family of sodium-amino acid co-transporters. Pflugers Arch. 2014;466(1):155–172. doi: 10.1007/s00424-013-1393-y. PubMed DOI

Calejo AI, Reverendo M, Silva VS, Pereira PM, Santos MAS, Zorec R, Goncalves PP. Differences in the expression pattern of HCN isoforms among mammalian tissues: sources and implications. Mol Biol Rep. 2014;41(1):297–307. doi: 10.1007/s11033-013-2862-2. PubMed DOI

Chen LQ, Cheung LS, Feng L, Tanner W, Frommer WB. Transport of sugars. Annu Rev Biochem. 2015;84:865–894. doi: 10.1146/annurev-biochem-060614-033904. PubMed DOI

Chen X, Hartman A, Guo S. Choosing cell fate through a dynamic cell cycle. Current Stem Cell Rep. 2015;1(3):129–138. doi: 10.1007/s40778-015-0018-0. PubMed DOI PMC

Choi JS, Berdis AJ. Nucleoside transporters: biological insights and therapeutic applications. Future Med Chem. 2012;4(11):1461–1478. doi: 10.4155/fmc.12.79. PubMed DOI

DiFrancesco JC, DiFrancesco D. Dysfunctional HCN ion channels in neurological diseases. Front Cell Neurosci. 2015 PubMed PMC

Guo SQ, Zi XY, Schulz VP, Cheng JJ, Zhong M, Koochaki SHJ, Megyola CM, Pan XH, Heydari K, Weissman SM, Gallagher PG, Krause DS, Fan R, Lu J. Nonstochastic reprogramming from a privileged somatic cell state. Cell. 2014;156(4):649–662. doi: 10.1016/j.cell.2014.01.020. PubMed DOI PMC

Hindley C, Philpott A. The cell cycle and pluripotency. Biochem J. 2013;451:135–143. doi: 10.1042/BJ20121627. PubMed DOI PMC

Hyka-Nouspikel N, Desmarais J, Gokhale PJ, Jones M, Meuth M, Andrews PW, Nouspikel T. Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells. Stem Cells. 2012;30(9):1901–1910. doi: 10.1002/stem.1177. PubMed DOI

Jovic D, Sakaue-Sawano A, Abe T, Cho C-S, Nagaoka M, Miyawaki A, Akaike T. Direct observation of cell cycle progression in living mouse embryonic stem cells on an extracellular matrix of E-cadherin. SpringerPlus. 2013;2:585. doi: 10.1186/2193-1801-2-585. PubMed DOI PMC

Koledova Z, Kafkova LR, Calabkova L, Krystof V, Dolezel P, Divoky V. Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells. Stem Cells Dev. 2010;19(2):181–193. doi: 10.1089/scd.2009.0065. PubMed DOI

Lau YT, Wong CK, Luo JL, Leung LH, Tsang PF, Bian ZX, Tsang SY. Effects of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers on the proliferation and cell cycle progression of embryonic stem cells. Pflugers Arch. 2011;461(1):191–202. doi: 10.1007/s00424-010-0899-9. PubMed DOI

Li VC, Kirschner MW. Molecular ties between the cell cycle and differentiation in embryonic stem cells. Proc Natl Acad Sci USA. 2014;111(26):9503–9508. doi: 10.1073/pnas.1408638111. PubMed DOI PMC

Li VC, Ballabeni A, Kirschner MW. Gap 1 phase length and mouse embryonic stem cell self-renewal. Proc Natl Acad Sci USA. 2012;109(31):12550–12555. doi: 10.1073/pnas.1206740109. PubMed DOI PMC

Liljelund P, Ferguson C, Homanics G, Olsen RW. Long-term effects of diazepam treatment of epileptic GABAA receptor beta3 subunit knockout mouse in early life. Epilepsy Res. 2005;66(1–3):99–115. doi: 10.1016/j.eplepsyres.2005.07.005. PubMed DOI

Lin TX, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol. 2005;7(2):U165–U180. doi: 10.1038/ncb1211. PubMed DOI

Mummery CL, Vanrooijen MA, Vandenbrink SE, Delaat SW. Cell-cycle analysis during retinoic acid-induced differentiation of a human embryonal carcinoma-derived cell-line. Cell Differ. 1987;20(2–3):153–160. doi: 10.1016/0045-6039(87)90429-5. PubMed DOI

Rodriguez-Gomez JA, Levitsky KL, Lopez-Barneo J. T-type Ca2+ channels in mouse embryonic stem cells: modulation during cell cycle and contribution to self-renewal. Am J Physiol Cell Physiol. 2012;302(3):C494–C504. doi: 10.1152/ajpcell.00267.2011. PubMed DOI

Ruiz S, Panopoulos AD, Herrerias A, Bissig KD, Lutz M, Berggren WT, Verma IM, Izpisua Belmonte JC. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Current biology CB. 2011;21(1):45–52. doi: 10.1016/j.cub.2010.11.049. PubMed DOI PMC

Savatier P, Huang S, Szekely L, Wiman KG, Samarut J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem-cells and embryonic fibroblasts. Oncogene. 1994;9(3):809–818. PubMed

Savatier P, Lapillonne H, Jirmanova L, Vitelli L, Samarut J. Analysis of the cell cycle in mouse embryonic stem cells. In: Turksen K, editor. Embryonic stem cells, vol 185. Methods in molecular biology™. New York: Springer; 2002. pp. 27–33. PubMed

Sidorova JM, Breeden LL. Precocious S-phase entry in pudding yeast prolongs replicative state and increases dependence upon Rad53 for viability. Genetics. 2002;160(1):123–136. PubMed PMC

Singh AM, Chappell J, Trost R, Lin L, Wang T, Tang J, Wu H, Zhao SY, Jin P, Dalton S. Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Rep. 2013;1(6):532–544. doi: 10.1016/j.stemcr.2013.10.009. PubMed DOI PMC

Smith A. Culture and differentiation of embryonic stem cells. J Tissue Culture Methods. 1991;13(2):89–94. doi: 10.1007/BF01666137. DOI

Solovei I, Schermelleh L, Albiez H, Cremer T. Chapter 35—Detection of cell cycle stages in situ in growing cell populations. In: Celis JE, editor. Cell biology. 3. Burlington: Academic Press; 2006. pp. 291–299.

Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D, Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene. 2002;21(54):8320–8333. doi: 10.1038/sj.onc.1206015. PubMed DOI

Strick R, Strissel PL, Gavrilov K, Levi-Setti R. Cation-chromatin binding as shown by ion microscopy is essential for the structural integrity of chromosomes. J Cell Biol. 2001;155(6):899–910. doi: 10.1083/jcb.200105026. PubMed DOI PMC

Tabar V, Studer L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet. 2014;15(2):82–92. doi: 10.1038/nrg3563. PubMed DOI PMC

Tamm C, Galito SP, Anneren C. A comparative study of protocols for mouse embryonic stem cell culturing. PLoS One. 2013 PubMed PMC

Tu WZ, Li B, Huang B, Wang Y, Liu XD, Guan H, Zhang SM, Tang Y, Rang WQ, Zhou PK. gamma H2AX foci formation in the absence of DNA damage: mitotic H2AX phosphorylation is mediated by the DNA-PKcs/CHK2 pathway. FEBS Lett. 2013;587(21):3437–3443. doi: 10.1016/j.febslet.2013.08.028. PubMed DOI

Wang K, Xue T, Tsang SY, Van Huizen R, Wong CW, Lai KW, Ye ZH, Cheng LZ, Au KW, Zhang J, Li GR, Lau CP, Tse HF, Li RA. Electrophysiological properties of pluripotent human and mouse embryonic stem cells. Stem Cells. 2005;23(10):1526–1534. doi: 10.1634/stemcells.2004-0299. PubMed DOI

Wang Z, Oron E, Nelson B, Razis S, Ivanova N. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell. 2012;10(4):440–454. doi: 10.1016/j.stem.2012.02.016. PubMed DOI

Wu X, Liao LP, Liu XM, Luo F, Yang TM, Li CH. Is ZD7288 a selective blocker of hyperpolarization-activated cyclic nucleotide-gated channel currents? Channels. 2012;6(6):438–442. doi: 10.4161/chan.22209. PubMed DOI PMC

Yang VS, Carter SA, Hyland SJ, Tachibana-Konwalski K, Laskey RA, Gonzalez MA. Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog. Curr Biol. 2011;21(8):692–699. doi: 10.1016/j.cub.2011.03.026. PubMed DOI PMC

Ying QL, Smith AG. Defined conditions for neural commitment and differentiation. Methods Enzymol. 2003;365:327–341. doi: 10.1016/S0076-6879(03)65023-8. PubMed DOI

Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A. The ground state of embryonic stem cell self-renewal. Nature. 2008;453(7194):515–519. doi: 10.1038/nature06968. PubMed DOI PMC